Abstract: Novel injectable depot gel or implant compositions comprising at least one active agent(s) selected from a group comprising antipsychotics, aromatase inhibitors, alpha-1 adrenergic blocking agents, acetylcholinesterase inhibitors, and pharmaceutically acceptable salts, derivatives, isomers, polymorphs, solvates, hydrates, analogues, enantiomers, tautomeric forms or mixtures thereof; at least one biocompatible bioerodible polymer(s); at least one biocompatible non-toxic solvent(s) and optionally one or more pharmaceutically acceptable excipient(s) are provided. The present invention also describes process for preparation of such novel compositions and method of using such compositions.
| # | Name | Date |
|---|---|---|
| 1 | 2321-del-2007-abstract.pdf | 2011-08-21 |
| 1 | 2321-del-2007-form-2.pdf | 2011-08-21 |
| 2 | 2321-del-2007-correspondence-others.pdf | 2011-08-21 |
| 2 | 2321-del-2007-form-1.pdf | 2011-08-21 |
| 3 | 2321-del-2007-description (provisional).pdf | 2011-08-21 |
| 4 | 2321-del-2007-correspondence-others.pdf | 2011-08-21 |
| 4 | 2321-del-2007-form-1.pdf | 2011-08-21 |
| 5 | 2321-del-2007-abstract.pdf | 2011-08-21 |
| 5 | 2321-del-2007-form-2.pdf | 2011-08-21 |